Twist Bioscience Corporation (TWST)

Twist Bioscience Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Equivalents	148.59	183.05	226.32	286.47	378.69	465.83
Short-Term Investments	49.36	49.39	50.08	49.94	126.28	12.03
Cash & Short-Term Investments	197.95	232.43	276.4	336.41	504.97	477.86
Cash Growth	-26.91%	-15.91%	-17.84%	-33.38%	5.67%	64.78%
Accounts Receivable	50.06	57.02	34.9	44.06	40.29	28.55
Inventory	32.92	28.31	24.08	32.06	39.31	31.8
Other Current Assets	22.95	15.2	11.4	11.72	11.91	8.28
Total Current Assets	303.88	332.97	346.78	424.26	596.48	546.5
Net Property, Plant & Equipment	177.39	151.66	161.35	203.36	214.39	105.7
Other Intangible Assets	13.16	13.43	14.48	54.48	59.74	18.26
Goodwill	82.2	82.2	85.81	85.81	85.81	22.43
Long-Term Investments	54.34	54.34	1.53	-	-	-
Other Long-Term Assets	7.12	7.28	4.38	8.49	4.96	9.2
Total Assets	638.09	641.86	614.32	776.4	961.38	702.1
Accounts Payable	12.49	11.09	1.63	14.05	20.09	14.9
Accrued Expenses	42.24	54.34	48.75	36.57	37.19	28.76
Current Portion of Long-Term Debt	-	-	-	-	-	1.55
Current Portion of Leases	12.24	13.82	14.81	14.9	13.64	8.21
Other Current Liabilities	13.47	12.15	5.82	7.8	19.74	9.62
Total Current Liabilities	80.44	91.41	71.01	73.32	90.66	63.05
Long-Term Leases	85.81	61.75	70.22	79.17	81.27	53.16
Other Long-Term Liabilities	15.74	15.75	0.41	0.48	0.06	5.07
Total Long-Term Liabilities	101.55	77.5	70.63	79.65	81.33	58.22
Total Liabilities	181.99	168.9	141.63	152.97	171.99	121.28
Additional Paid-in Capital	1,807	1,793	1,715	1,657	1,620	1,191
Accumulated Other Comprehensive Income	-0.57	-0.63	-0.62	-0.76	-1.84	0.55
Retained Earnings	-1,350	-1,320	-1,242	-1,033	-828.42	-610.55
Shareholders' Equity	456.1	472.96	472.69	623.43	789.39	580.82
Total Liabilities & Equity	638.09	641.86	614.32	776.4	961.38	702.1
Total Debt	98.05	75.57	85.03	94.07	94.91	62.92
Net Cash (Debt)	99.9	156.86	191.37	242.34	410.06	414.94
Net Cash Growth	-36.31%	-18.03%	-21.03%	-40.90%	-1.18%	63.35%
Net Cash Per Share	1.65	2.62	3.30	4.26	7.61	8.60
Book Value	456.1	472.96	472.69	623.43	789.39	580.82
Book Value Per Share	7.53	7.91	8.15	10.96	14.65	12.04
Tangible Book Value	360.74	377.34	372.4	483.14	643.84	540.13
Tangible Book Value Per Share	5.95	6.31	6.42	8.49	11.95	11.19

Updated Feb 2, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q